Senators probe Valeant and Shkreli over drug prices, while House Dems form a task force
Consumers are angry over prescription drug costs and now all three branches of the federal government are trying to take action. A pair of US Senators has opened an investigation into prescription drug pricing in response to growing reports of companies buying medicines and then raising prices to previously unforeseen heights.
Separately, the secretary of the US Department of Health and Human Services plans to hold a day-long conference on Nov. 20 to look at ways of speeding the discovery of innovative drugs, but also discuss how medicines can be made more affordable. Meanwhile, some House Democrats formed a new task force on drug pricing and are pressing to have subpoenas issued to Martin Shkreli’s Turing Pharmaceuticals and Valeant Pharmaceuticals.